Psykey, Inc.
CEOSOTCHealthcare● Active
$0.00
$-0.00(-39.19%)
Market Cap$64600
P/E Ratio—
52W High$0.0125
52W Low$0.0006
Psykey, Inc. (CEOS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CEOS · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2024Report Date: Aug 14, 2024EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Aug 14, 2024
After Market Close
CEOS reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2025 | Aug 18, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 29, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Feb 26, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Nov 22, 2024 | — | — | — | — | — | — |
| — Q3 FY2024 | Aug 14, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2024 | May 15, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2023 | Dec 30, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2023 | Sep 29, 2023 | — | -$0.00 | — | $0.00B | — | — |
Q3 FY2025
Aug 18, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 29, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Feb 26, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 22, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 14, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 15, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Dec 30, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2023
Sep 29, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2024 | Aug 14, 2024 | — | $0.03 | $0.03 | -3.56% |
| — Q2 FY2024 | May 15, 2024 | — | $0.02 | $0.01 | -10.16% |
| — Q4 FY2023 | Dec 30, 2023 | — | $0.03 | $0.03 | +9.32% |
| — Q3 FY2023 | Sep 29, 2023 | — | $0.01 | $0.02 | +14.44% |
| — Q2 FY2023 | Jun 29, 2023 | — | $0.04 | $0.04 | -0.35% |
| — Q1 FY2023 | Mar 30, 2023 | — | $0.03 | $0.03 | -0.43% |
| — Q4 FY2022 | Dec 30, 2022 | — | $0.01 | $0.01 | +1.08% |
| — Q3 FY2022 | Sep 29, 2022 | — | $0.03 | $0.04 | +4.79% |
Q3 FY2024-3.56%
Report Date
Aug 14, 2024
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q2 FY2024-10.16%
Report Date
May 15, 2024
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.01
Q4 FY2023+9.32%
Report Date
Dec 30, 2023
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q3 FY2023+14.44%
Report Date
Sep 29, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.02
Q2 FY2023-0.35%
Report Date
Jun 29, 2023
EPS Beat/Miss
—
Price Before
$0.04
Price After
$0.04
Q1 FY2023-0.43%
Report Date
Mar 30, 2023
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q4 FY2022+1.08%
Report Date
Dec 30, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2022+4.79%
Report Date
Sep 29, 2022
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.04
Beat Rate0 / 8 quarters
Largest Move+14.44% (Q3 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CEOS ends December
Psykey, Inc. (CEOS) most recently reported earnings on August 14, 2024 for Q3 FY2024, posting EPS of $-0.00 (in line with the analyst consensus of —). The next CEOS earnings date is expected around September 1, 2026.
Each quarter, investors track CEOS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CEOS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CEOS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CEOS earnings · 4 questionsPsykey, Inc.'s next earnings report is expected around September 1, 2026. CEOS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CEOS historically reports after market close (AMC).
CEOS earnings datewhen is CEOS earningsCEOS next earnings datewhen does CEOS report earningsCEOS earnings calendar
▸ Source: FMP · Psykey, Inc. SEC filings · US GAAP · Psykey, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026